Showing results (171-180 of 178) with videos related to
Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 178 results.
Diagnostic Microbiology and Infectious Disease|March 16, 2010
Microfluidic platform versus conventional real-time polymerase chain reaction for the detection of Mycoplasma pneumoniae in respiratory specimensElizabeth Wulff-Burchfield, Wiley A Schell, Allen E Eckhardt, et al.Journal of Clinical Microbiology|November 14, 2014
Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremiaBatu K Sharma-Kuinkel, Yuling Wu, David E Tabor, et al.Applied and Environmental Microbiology|May 29, 2007
Ecological genomics of marine RoseobactersM A Moran, R Belas, M A Schell, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 2, 2010
Fatal Apophysomyces elegans infection transmitted by deceased donor renal allograftsB D Alexander, W A Schell, A M Siston, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 9, 2004
Native valve endocarditis due to Candida glabrata treated without valvular replacement: a potential role for caspofungin in the induction and maintenance treatmentM J Jiménez-Expósito, G Torres, A Baraldés, et al.Antimicrobial Agents and Chemotherapy|March 7, 2012
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosineA Espinel-Ingroff, A Chowdhary, M Cuenca-Estrella, et al.Antimicrobial Agents and Chemotherapy|September 6, 2012
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazoleA Espinel-Ingroff, A I Aller, E Canton, et al.Journal of Clinical Microbiology|August 7, 2004
Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus speciesFrank C Odds, Mary Motyl, Roberto Andrade, et al.Pageof 18